A detailed history of Chicago Trust CO Na transactions in Amgen Inc stock. As of the latest transaction made, Chicago Trust CO Na holds 7,650 shares of AMGN stock, worth $2.14 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
7,650
Previous 7,767 1.51%
Holding current value
$2.14 Million
Previous $2.43 Million 1.57%
% of portfolio
0.53%
Previous 0.59%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$309.38 - $337.38 $36,197 - $39,473
-117 Reduced 1.51%
7,650 $2.46 Million
Q2 2024

Jul 11, 2024

SELL
$262.75 - $319.31 $189,180 - $229,903
-720 Reduced 8.48%
7,767 $2.43 Million
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $137,930 - $166,499
513 Added 6.43%
8,487 $2.41 Million
Q4 2023

Jan 16, 2024

SELL
$255.7 - $288.46 $29,661 - $33,461
-116 Reduced 1.43%
7,974 $2.3 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $47,009 - $58,363
215 Added 2.73%
8,090 $2.17 Million
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $46,282 - $54,727
216 Added 2.82%
7,875 $1.75 Million
Q1 2023

Apr 11, 2023

SELL
$225.79 - $275.2 $257,174 - $313,452
-1,139 Reduced 12.95%
7,659 $1.85 Million
Q4 2022

Jan 12, 2023

BUY
$229.03 - $291.01 $110,392 - $140,266
482 Added 5.8%
8,798 $2.31 Million
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $45,340 - $51,136
-202 Reduced 2.37%
8,316 $1.88 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $143,040 - $159,178
620 Added 7.85%
8,518 $2.07 Million
Q1 2022

Apr 12, 2022

SELL
$219.27 - $242.57 $43,634 - $48,271
-199 Reduced 2.46%
7,898 $1.91 Million
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $15,910 - $18,208
-80 Reduced 0.98%
8,097 $1.82 Million
Q3 2021

Oct 13, 2021

SELL
$212.27 - $248.7 $134,791 - $157,924
-635 Reduced 7.21%
8,177 $1.74 Million
Q2 2021

Jul 21, 2021

BUY
$233.58 - $259.14 $1.31 Million - $1.45 Million
5,603 Added 174.6%
8,812 $2.15 Million
Q1 2021

Apr 12, 2021

SELL
$221.91 - $258.6 $91,648 - $106,801
-413 Reduced 11.4%
3,209 $798,000
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $43,059 - $51,276
199 Added 5.81%
3,622 $833,000
Q3 2020

Oct 08, 2020

BUY
$234.65 - $260.95 $11,497 - $12,786
49 Added 1.45%
3,423 $870,000
Q2 2020

Jul 13, 2020

BUY
$197.81 - $242.74 $19,781 - $24,274
100 Added 3.05%
3,374 $796,000
Q1 2020

Apr 07, 2020

SELL
$182.24 - $241.7 $12,756 - $16,919
-70 Reduced 2.09%
3,274 $664,000
Q4 2019

Jan 13, 2020

SELL
$189.21 - $243.2 $29,327 - $37,696
-155 Reduced 4.43%
3,344 $807,000
Q3 2019

Oct 09, 2019

SELL
$174.11 - $208.62 $37,781 - $45,270
-217 Reduced 5.84%
3,499 $677,000
Q2 2019

Jul 23, 2019

BUY
$166.7 - $195.41 $16,670 - $19,541
100 Added 2.77%
3,716 $685,000
Q1 2019

Apr 10, 2019

SELL
$180.87 - $203.88 $18,087 - $20,388
-100 Reduced 2.69%
3,616 $687,000
Q3 2018

Oct 10, 2018

SELL
$185.29 - $208.89 $13,896 - $15,666
-75 Reduced 1.98%
3,716 $771,000
Q2 2018

Jul 12, 2018

SELL
$166.05 - $186.51 $246,916 - $277,340
-1,487 Reduced 28.17%
3,791 $700,000
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $1.45 Million - $1.7 Million
-8,581 Reduced 61.92%
5,278 $900,000
Q4 2017

Jan 17, 2018

SELL
$168.79 - $188.59 $31,901 - $35,643
-189 Reduced 1.35%
13,859 $2.41 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $2.35 Million - $2.68 Million
14,048
14,048 $2.62 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chicago Trust CO Na Portfolio

Follow Chicago Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Trust CO Na with notifications on news.